Ariavax
2000
FOUNDED
PRIVATE
STATUS
Grant
LATEST DEAL TYPE
$556K
LATEST DEAL AMOUNT
2
INVESTORS
Description
Developer of a vaccine against urinary tract infection. The company's vaccines are based on its proprietary peptide chemistry technology.
Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Primary Office
- 708 Quince Orchard Road
- Gaithersburg, MD 20878
- United States
+1 (240) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Ariavax’s full profile, request a free trial.
Ariavax Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Grant | 01-Feb-2009 | $556K | Completed | Generating Revenue | ||
| 2. Grant | 01-May-2005 | 00000 | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | Completed | Startup |
Ariavax Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Maryland Industrial Partnerships | Accelerator/Incubator | 000 0000 | 000000 0 | |||
| TEDCO | Venture Capital | Minority | 000 0000 | 000000 0 |